• LY364947: TGF-β Type I Receptor Kinase Inhibitor

  2026-08-31

  LY364947 enables controlled interrogation of TGF-β-driven Smad2 signaling, EMT, fibrosis, and retinal injury biology. This practical guide connects reagent handling with orthogonal assays and explains how the compound can test pathway crosstalk highlighted in pancreatic cancer research.

• ATG9A, PTOV1, and 14-3-3 Cancer Mechanisms

  2026-08-31

  The reference study identifies ATG9A and PTOV1 as previously unrecognized 14-3-3-interacting proteins and defines distinct mechanisms linking them to autophagy, protein stability, and oncogenic signaling. Its combination of BioID proteomics, quantitative turnover analysis, and biochemical validation provides a useful framework for studying context-dependent protein interactions in cancer biology.

• HyperScribe T7 Cy3 RNA Labeling Kit Guide

  2026-08-30

  The HyperScribe T7 High Yield Cy3 RNA Labeling Kit is a 25-reaction in vitro transcription system for randomly Cy3-modified RNA probes. Its tunable Cy3-UTP-to-UTP strategy supports fluorescent probes for in situ hybridization and Northern blot workflows, but it should not be confused with an mRNA delivery reagent.

• Phosphatase Inhibitor Cocktail 1: Assay Logic

  2026-08-29

  Phosphatase Inhibitor Cocktail 1 helps protect labile phosphorylation signals during sample preparation. This article connects inhibitor selection to the RSAD2–interferon biology of SLE pregnancies, emphasizing assay-specific controls, preanalytical rigor, and interpretation limits.

• N-MYC–eIF4G1 Signaling in inv(16) AML

  2026-08-28

  Peramangalam et al. identify a previously unrecognized MYCN enhancer and define an N-MYC–eIF4G1 survival axis in inv(16) acute myeloid leukemia. By integrating transcriptomic, regulatory-element, genetic, cellular, and xenograft analyses, the study links CBFβ-SMMHC activity to a targetable leukemic maintenance program.

• HyperScribe T7 High Yield Cy3 RNA Labeling Kit: Assay Design

  2026-08-28

  The HyperScribe T7 High Yield Cy3 RNA Labeling Kit supports controlled fluorescent RNA probe synthesis for ISH and Northern blotting. This guide connects Cy3-UTP labeling decisions with RNAi assay interpretation, using a recent Bemisia tabaci nanocarrier study to define practical controls and limitations.

• Crizotinib Hydrochloride: ALK Kinase Inhibitor

  2026-08-27

  Crizotinib hydrochloride is an ATP-competitive ALK kinase inhibitor that also targets c-Met and ROS1 for mechanistic cancer biology research. Its phosphorylation readouts and compatibility with patient-derived assembloid workflows support context-specific studies, but the gastric assembloid reference does not establish compound-specific efficacy.

• S-Adenosylhomocysteine: The Methylation Brake

  2026-08-27

  S-Adenosylhomocysteine (SAH) is more than a methyltransferase byproduct: it is a ratio-sensitive metabolic checkpoint that can sharpen translational studies of methylation, homocysteine metabolism, and stress-induced cell-state changes.

• Rotigotine hydrochloride: Applied Research Workflows

  2026-08-26

  Build more reproducible dopaminergic signaling experiments with Rotigotine hydrochloride, from cell-based neuroprotection screens to Parkinson’s disease and motor-disorder models. This guide combines practical dosing, delivery, stability, impurity-control, and troubleshooting strategies for translationally minded workflows.

• Carrier-Platin and Rapid ROS-Driven Cancer Cell Death

  2026-08-26

  Liu et al. developed carrier-platin, a platinum nanotherapeutic that confines ultrasmall platinum nanoparticles within a poly(amino acids) carrier to generate a rapid intracellular ROS burst. The resulting cancer-cell death is independent of DNA damage and differs from canonical apoptosis and ferroptosis, suggesting a potential strategy for tumors with multidrug resistance, although substantial translational questions remain.

• Serotonin Inhibition of HRP Protein Labelling

  2026-08-25

  The reference study identifies serotonin as a previously unrecognized inhibitor of HRP-mediated proximity biotinylation, while dopamine shows little interference under the tested conditions. It also demonstrates that Dz-PEG can consume serotonin and restore labelling efficiency, providing a practical control strategy for serotonergic neuronal proteomics.

• Streptavidin-HyperFluor 647: A Smarter Assay Map

  2026-08-24

  Streptavidin-HyperFluor 647 connects biotin labeling chemistry to sensitive red-fluorescence readouts. This guide explains when a Streptavidin fluorescent conjugate is preferable to biotin-free click-compatible strategies and how to design interpretable microscopy, flow, and FRET assays.

• IWR-1-endo Workflow for Wnt Signaling Research

  2026-08-24

  IWR-1-endo provides a practical way to suppress Wnt/β-catenin activity in colorectal cancer, stem-cell, zebrafish, and image-based phenotyping workflows. This guide connects Axin-complex biology with reproducible dosing, morphology profiling, controls, and troubleshooting while clarifying how the CARDIO study can inform assay design without overstating its findings.

• Azathramycin A: A Smarter TB Assay Framework

  2026-08-23

  Azathramycin A is a macrolide antibiotic for mechanistic tuberculosis research, with ribosome-focused activity and useful stress-degradation characteristics. This guide develops a matrix-aware assay framework that connects target engagement, infection-model design, and antibiotic resistance research without overstating evidence across species.

• Deferasirox and the Iron Logic of Ferroptosis

  2026-08-22

  Deferasirox is an oral iron chelator with established value in transfusional iron overload and emerging utility as a mechanistic probe for tumor iron biology. This article connects its iron-binding, mitochondrial ROS, and myeloid effects with the METTL16–SENP3–LTF ferroptosis-resistance axis in hepatocellular carcinoma, while outlining experiments that separate iron depletion from lysosomal, apoptotic, and ferroptotic stress.

8600 records 1/574 page Next 12345 下5页 Last page